Founded in 2014 and headquartered in Shenzhen, HugeMed, a medical device manufacturer awarded National High-Tech Enterprise and “Little Giant” SMEs, is dedicated to providing cutting‐edge endoscopic treatment solutions worldwide.
To bring quality endoscopy to all people in need, after a decade of independent R&D and global expansion, HugeMed has launched single-use and reusable endoscopes for multiple departments, including anesthesiology, pulmonology, urology, general surgery, gastroenterology, and gynecology. We rank among the top players in the single-use flexible ureteroscope market across multiple countries, establishing a urology-centered portfolio with multiple product lines advancing in tandem.
For innovation: Each year we invest 25% of our sales revenue into R&D, collaborating with the Chinese Academy of Sciences and international academicians to make breakthroughs in advanced technologies, and have acquired hundreds of patents.
For manufacturing: We now operate production facilities covering over 10,000 square meters, with a current maximum monthly production capacity over 50,000 units. In the future, we plan to establish the Second Manufacturing Center, increasing annual capacity to 1,000,000 units.
For sales: As a pioneer in global expansion, we are constantly exploring new market strongholds. We have obtained hundreds of certifications including NMPA, CE, FDA, and MDSAP. Our sales network spans over 100 countries and regions, with partnerships established with more than 10,000 hospitals worldwide.
For customers service: In China, we offer 24/7 after-sales service, while abroad, we work closely with our local distributors to build offshore service networks.
With a heart devoted to the health of mankind, we pursue the path towards great achievements. Looking forward, we will uphold our sustainable development strategy of "relentless innovation, resource integration, and steady growth," and continuously strive towards our mission of becoming the leading supplier of single-use endoscopes in the world.





